Brian White
Pulmonary Disease · Ravenna, OHNPI 1124039649
Payments from drug & device makers
Across 170 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$615
- AstraZeneca$592
- Boehringer Ingelheim$494
- Sanofi$161
- Regeneron Healthcare Solutions, Inc.$148
- Actelion Pharmaceuticals US, Inc.$142
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,19295%
- Education$1725%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$125
- ACTHAR$104
How this compares
$3,364 in reported general payments places this provider in the 55th percentile of 571 pulmonary disease providers in Ohio.
Other pulmonary disease in Ravenna
- Bruce CorserCincinnati$8.2M
- Edward CordascoColumbus$8M
- Kristin HighlandCleveland$3.2M
- Brian ZenoColumbus$2.9M
- Jean ElwingCincinnati$2.4M
- Roy St JohnColumbus$1.9M
- Nishant GuptaCincinnati$1.5M
- Robert BaughmanCincinnati$1.1M
- Francis McCormackCincinnati$1.1M
- Leslie TolleCleveland$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.